Filtros

Buscador
Año
Ferenczi S, Núñez C, Pintér-Kübler B, Földes A, Martín F, Márkus VL, Milanés MV, Kovács KJ. Changes in metabolic-related variables during chronic morphine treatment. Neurochem Int. 2010 Oct;57(3):323-30. doi: 10.1016/j.neuint.2010.06.011. Epub 2010 Jun 26. PubMed PMID: 20600437.
AÑO: 2010; IF: 3.601
Núñez C, Földes A, Pérez-Flores D, García-Borrón JC, Laorden ML, Kovács KJ, Milanés MV. Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawal. Endocrinology. 2009 Jul;150(7):3118-27. doi: 10.1210/en.2008-1732. Epub 2009 Jan 29. PubMed PMID: 19179436; PubMed Central PMCID: PMC2703550.
AÑO: 2009; IF: 4.752
Núñez C, González-Cuello A, Sánchez L, Vargas ML, Milanés MV, Laorden ML. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus. Eur J Pharmacol. 2009 Oct 12;620(1-3):1-8. doi: 10.1016/j.ejphar.2009.08.002. Epub 2009 Aug 14. PubMed PMID: 19683523.
AÑO: 2009; IF: 2.585
Núñez C, Castells MT, Laorden ML, Milanés MV. Regulation of extracellular signal-regulated kinases (ERKs) by naloxone-induced morphine withdrawal in the brain stress system. Naunyn Schmiedebergs Arch Pharmacol. 2008 Oct;378(4):407-20. doi: 10.1007/s00210-008-0304-9. Epub 2008 Jun 12. PubMed PMID: 18548233.
AÑO: 2008; IF: 2.83
Nunez C, Földes A, Laorden ML, Milanes MV, Kovács KJ. Activation of stress-related hypothalamic neuropeptide gene expression during morphine withdrawal. J Neurochem. 2007 May;101(4):1060-71. Epub 2007 Feb 5. PubMed PMID: 17286593.
AÑO: 2007; IF: 4.451